[HTML][HTML] Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

R Honda, H Tanaka, H Yasuda - FEBS letters, 1997 - Elsevier
R Honda, H Tanaka, H Yasuda
FEBS letters, 1997Elsevier
The tumor suppressor p53 is degraded by the ubiquitin-proteasome system. p53 was
polyubiquitinated in the presence of E1, UbcH5 as E2 and MDM2 oncoprotein. A ubiquitin
molecule bound MDM2 through sulfhydroxy bond which is characteristic of ubiquitin ligase
(E3)-ubiquitin binding. The cysteine residue in the carboxyl terminus of MDM2 was essential
for the activity. These data suggest that the MDM2 protein, which is induced by p53,
functions as a ubiquitin ligase, E3, in human papillomavirus-uninfected cells which do not …
The tumor suppressor p53 is degraded by the ubiquitin-proteasome system. p53 was polyubiquitinated in the presence of E1, UbcH5 as E2 and MDM2 oncoprotein. A ubiquitin molecule bound MDM2 through sulfhydroxy bond which is characteristic of ubiquitin ligase (E3)-ubiquitin binding. The cysteine residue in the carboxyl terminus of MDM2 was essential for the activity. These data suggest that the MDM2 protein, which is induced by p53, functions as a ubiquitin ligase, E3, in human papillomavirus-uninfected cells which do not have E6 protein.
Elsevier